2. Sallam M. ChatGPT utility in healthcare education, research, and practice: systematic review on the promising perspectives and valid concerns. Healthcare (Basel). 2023; 11:887.
3. Biswas SS. Role of chat GPT in public health. Ann Biomed Eng. 2023; 51:868–9.
4. Kim JH, Kim SK, Choi J, Lee Y. Reliability of ChatGPT for performing triage task in the emergency department using the Korean triage and acuity scale. Digit Health. 2024; 10:20552076241227132.
5. DiGiorgio AM, Ehrenfeld JM. Artificial intelligence in medicine & ChatGPT: de-tether the physician. J Med Sys. 2023; 47:32.
Article
6. Johnson SB, King AJ, Warner EL, Aneja S, Kann BH, Bylund CL. Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI Cancer Spectr. 2023; 7:pkad015.
7. Han JY, Nava-Ocampo AA, Koren G. Unintended pregnancies and exposure to potential human teratogens. Birth Defects Res A Clin Mol Teratol. 2005; 73:245–8.
8. Vuignier Y, Beaud F, Kosinski C, Panchaud A, Lebon S, Baud D, et al. Exposure to alirocumab during the first trimester of pregnancy: a case report. Birth Defects Res. 2021; 113:1156–60.
9. Abdulaziz HM, Shemies RS, Taman M, Mosbah A, Elkannishy G. Fetal proximal and distal limb anomalies following exposure to mycophenolate mofetil during pregnancy: a case report and review of the literature. Lupus. 2021; 30:1522–5.
10. Cha EH, Kim N, Kwak HS, Han HJ, Joo SH, Choi JS, et al. Pregnancy and neonatal outcomes after periconceptional exposure to isotretinoin in Koreans. Obstet Gynecol Sci. 2022; 65:166–75.
Article
11. Lee YR, Hwang DW, Chun KC, Kim YA, Koh JW, Han JY, et al. Termination of pregnancy following periconception isotretinoin exposure in South Korea. Clin Exp Obstet Gynecol. 2024; 51:144.
13. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams obstetrics. 25th ed. New York (NY): Mcgraw-hill;2014.
15. AlGhamdi KM, Khurram H, Asiri YA, Mandil A. Dermatologists’ level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential. Int J Dermatol. 2011; 50:1094–8.
16. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985; 313:837–41.
17. Choi EJ, Kim N, Kwak HS, Han HJ, Chun KC, Kim YA, et al. The rates of major malformations after gestational exposure to isotretinoin: a systematic review and metaanalysis. Obstet Gynecol Sci. 2021; 64:364–73.
Article
18. Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for clinical teratology and drug risk assessment in pregnancy. Arch Gynecol Obstet. 2010; 281:221–7.
Article
19. You W, Choi A, Lee H, Han JY, Lee JH, Shin JY. Adverse pregnancy and child outcomes in oral retinoid-exposed pregnancies: a nationwide population-based study. J Korean Med Sci. 2024; 39:e201.
Article
20. Adams J, Lammer EJ. Relationship between dysmorphology and neuro-psychological function in children exposed to isotretinoin ‘in utero’. In : Fujii T, Boer GJ, editors. Functional neuroteratology of short term exposure to drugs. 1st ed. Tokyo: Teikyo University Press;1992. p. 159–70.
21. Adams J, Lammer EJ. Neurobehavioral teratology of isotretinoin. Reprod Toxicol. 1993; 7:175–7.
Article
22. Adams J. Structure-activity and dose-response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol. 1993; 15:193–202.
23. Olson CR, Mello CV. Significance of vitamin A to brain function, behavior and learning. Mol Nutr Food Res. 2010; 54:489–95.
Article